GCG and type 2 diabetes mellitus: Exempted is the first GLP-1 agonist approved for clinical use, lowering blood glucose in a glucose-dependent manner, rarely causing hypoglycaemia when used alone, reducing body mass and improving lipid metabolism and islet function in patients with type 2 diabetes mellitus (T2DM) patients, improving lipid metabolism and islet function.